Efficacy Study of Vx001 Vaccine in NSCLC Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Non-small Cell Lung Cancer Metastatic
Interventions
DRUG

Vx-001

DRUG

Placebo

Trial Locations (70)

10357

Oddział Onkologii z Pododdziałem Chemioterapii Nowotworów Płuc, Olsztyn

11525

251 General Airforce Hospital, Athens

11527

General hospital of thoracic diseases Sotiria, Athens

11528

Aretaieio Hospital, Athens

General Hospital Alexandra, Athens

12002

Hospital Provencial de Castellón, Castellon

13915

Hopital Nord, Marseille

14564

General Oncology Hospital of Kifissia Agioi Anargyroi, Nea Kifissia

15540

Uniwersytet Medyczny Bialistok, Bialystok

15562

Iaso General Hospital Cholargos, Athens

18008

Vseobecna fakultni nemocnice, Prague

20064

MS Clinsearch, Lublin

20141

European Institute of Oncology, Milan

20142

San Paolo Hospital, Milan

22927

Hospital Grosshansdorf, Großhansdorf

24116

University Medical center Kiel, Kiel

26121

Pius Hospital Oldenburg, Oldenburg

26504

University Hospital of Patras, Rio

28040

Oncologia Medica FUNDACIÓN JIMÉNEZ DÍAZ, Madrid

28222

Hospital Univesitario Puerta de Hierro, Madrid

29010

H.R.U. Carlos Haya Málaga, Málaga

30599

Fakultni nemocnice Plzen, Plzen-Bory

31108

Nzoz Vesalius, Krakow

32429

Mühlenkreiskliniken (AöR) Johannes Wesling Klinikum Minden, Minden

34125

Klinikum Kassel GmbH, Kassel

35033

Pontchaillou Hospital, Rennes

35128

Insituto Oncologico Veneto, Padua

42100

S. Maria Nuova Hospital, Reggio Emilia

45500

University General Hospital of Ioannina, Ioannina

46010

Hospital Clinico de Valencia, Valencia

48431

Mathias Spital Rheine Medizinische Klinik V, Rheine

49933

University Hospital of Angers, Angers

50098

Spitalul Universitar de Urgenta Bucuresti, Bucharest

53100

University Hospital of Siena, Siena

56126

A.O.U di Pisa Hospital, Pisa

56429

University General Hospital Papageorgiou, Thessaloniki

57010

General Hospital G. Papanikolaou, Thessaloniki

58675

Lungenklinik Hemer, Hemer

60693

Med-Polonia, Poznan

62500

Przychodnia KOMED, Konin

68100

University Hospital of Alexandroupolis, Alexandroupoli

68167

Chirurgische Klinik-Inderdisziplinäre Thorakale Oncologie, Mannheim

70891

Specjalistyczny Szpital im. prof.Alfreda Sokołowskiego, Szczecin

71110

University Hospital of Heraklion, Heraklion

74245

Klinik Löwenstein, Löwenstein

75651

Pitié-Salpetrière Hospital, Paris

80131

Seconda Universita degli Studi Napoli Hospital, Naples

80208

Hospicjum im. ks. T. Dutkiewicza SAC, Gdansk

80336

LMU Klinikum der Universität München, Munich

82100

G. Rummo Hospital, Benevento

83100

SG Moscati Hospital, Avellino

88100

Mater Domini Catanzaro Hospital, Catanzaro

92104

Ambroise Paré Hospital, Boulogne-Billancourt

200385

Oncolab SRL, Craiova

400015

"Institutului Oncologic Prof. Dr. I. Chiricuţă Cluj-Napoca", Cluj-Napoca

400058

Medisprof SRL, Cluj-Napoca

550245

Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu

06132

S. Maria della Misericordia Hospital, Perugia

05400

Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy w Otwocku, Otwock

02781

Centrum Onkologii - Instytut im. M. Skłodowskiej - Curie, Warsaw

Fundacja Hospicjum Onkologiczne św. Krzysztofa, Warsaw

Unknown

SC Oncopremium Team SRL, Baia Mare

Spit. Jud. de Urgenţă, Brăila

"Spitalul Clinic Judetean de Urgenta Sf. Ioan cel Nou", Suceava

Oncomed SRL, Department of Medical Oncology, Timișoara

Hospital Son Llatzer, Palma de Mallorca

08028

USP Institut Universitari Dexeus, Barcelona

08035

University Hospital P. Vall d'Hebron, Barcelona

08041

Hospital de la Santa Creu I Sant Pau, Barcelona

08916

Ico-Hospital Germans Trias I Pujol, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Vaxon Biotech

INDUSTRY

NCT01935154 - Efficacy Study of Vx001 Vaccine in NSCLC Patients | Biotech Hunter | Biotech Hunter